SUNPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > sunpharma

Technical Analysis

Technical Strength: 6.7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 59.3. According to RSI analysis, sunpharma is technically strong. 9.0 SUNPHARMA RSI Chart
MACD (?) MACD: 2.41 and Signal Line: 2.57. According to MACD analysis, sunpharma is marginally weak. 3.0 SUNPHARMA MACD Chart
Simple Moving Average (?) Price just got below it's 20-day simple moving average which is a negative signal. According to simple moving average analysis, sunpharma is in a strong uptrend. Major support levels are 483.18, 473.477, 432.8358. 6.0 SUNPHARMA Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, sunpharma is in a strong uptrend. Major support levels are 481.3518, 470.8035, 444.2904. 10.0 SUNPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.864. According to bollinger bands, sunpharma is technically strong. 7.0 SUNPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 482.7321 and 473.475. Resistance level is 512.7. 6.5 SUNPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 13.7 NA SUNPHARMA Average True Range Chart
Average Directional Index (?) ADX is 12.3 which means SUNPHARMA is in a trading range and there is no trend. NA SUNPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
July 10, 2020
Open Price 484.65
High Price 498.9
Low Price 483.05
Close Price 493.9
Absolute Change 11.95
Percentage Change 2.48%
Weekly Change 3.58%
Monthly Change 2.87%
Yearly Change 24.9%
52-week high 512.7
52-week low 312.0
Corporate Actions
ExDate Purpose
February 17, 2020 INT DIV-RS 3 PER SH
August 20, 2019 AGM/DIV-RS 2.75 PER SH
September 17, 2018 AGM/DIV RS 2 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.59
Confidence in Beta2.12%
Market Capital Rs. 102286.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 10 July 2020: Deliverable Quantity:2.38e+06 NA SUNPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 10 July 2020: Daily Volatility:0.4604 NA SUNPHARMA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 10 July 2020: PCR_OI:0.58 PCR:0.259 NA SUNPHARMA PCR Chart
Option Pain (?) 10 July 2020: Max Pain:490.0 NA SUNPHARMA Option Pain Chart
Premium (?) 10 July 2020 Premium: 0.9 Futures OI:28973000.0 NA SUNPHARMA Premium Chart
Option_MAX_OI (?) 10 July 2020: Price:493.9 Put with maximum OI:400.0 Call with maximum OI:500.0 NA SUNPHARMA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
July 30, 2020 494.8 28973000.0 11545.0 11545.0 493.9
August 27, 2020 495.3 274400.0 161.0 161.0 493.9
September 24, 2020 496.1 21000.0 4.0 4.0 493.9

Announcements

September 12, 2018 News Clarification The Exchange has sought clarification from the Company with respect to news item captioned-Sun Pharma Mohali plant on FDA radar In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.
April 26, 2018 SShareholders meetingSun Pharmaceutical Industries Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on Jun 01, 2018
See all Announcements

Board Meetings

Date Meeting Date Purpose
May 19, 2020 May 27, 2020 Financial Results/Dividend To consider and approve Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2020 and to consider recommendation of final dividend for the year ended March 31, 2020 subject to the approval of the shareholders at the ensuing Annual General Meeting.
March 13, 2020 March 17, 2020 Buyback To consider, inter alia, the proposal for buy-back of fully paid-up equity shares of the Company, which would include maximum amount, maximum number of equity shares, mode of buy-back and other matters incidental thereto in accordance with the provisions of Section 68, 69 and 70 of the Companies Act,2013, read with rules made thereto and Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018.
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play